Company news

Evotec SE news in 2025

Evotec SE's news releases, calls and decks from 2025, newest first.

View company

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

December 8, 2025

Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome

December 4, 2025

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

November 12, 2025

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

November 5, 2025

In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties

November 4, 2025

Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025

October 29, 2025

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

October 27, 2025

Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution

August 13, 2025

Evotec SE to announce first half-year results 2025 on 13 August 2025

August 6, 2025

Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site

July 30, 2025

Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site

July 30, 2025

Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix

July 21, 2025

Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance

July 21, 2025

Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury

June 25, 2025

Evotec SE: Results of the Annual General Meeting 2025

June 3, 2025

Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments

May 7, 2025

Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment

May 6, 2025

Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025

April 29, 2025

Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb

April 24, 2025

Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results

April 17, 2025

Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025

April 10, 2025

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb

March 4, 2025

Evotec Announces Change in Management Board

February 26, 2025

Calls in 2025

Decks in 2025